Bio-Rad Laboratories Inc. (BIO) Tops Q4 EPS Views; Revs Light
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $382.73 +0.98%
Revenue Growth %: -0.4%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -0.4%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q4 EPS of $2.08, $0.41 better than the analyst estimate of $1.67. Revenue for the quarter came in at $550.2 million versus the consensus estimate of $562.06 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Faraday Future says it regained Nasdaq compliance after equity shortfall
- Physician-Owned, Physician-Led Medical Spa Brand Healthy Solutions Medspa Launches Franchise for Doctors
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
